HUMANES BINDUNGSMOLEKÜL GEGEN CD1A

European patent · EP1706427 · Deleted

Register entry

Publication number
EP1706427
Application number
EP04804973
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 21, 2004
Published
Oct 4, 2006
Granted
Dec 7, 2011
Deleted
Dec 21, 2024
Reason
Maximum term reached
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
Priority
WO PCT/EP03/51096 23.12.2003
WO PCT/EP2004/052110 09.09.2004
PCT application
PCT/EP2004/053639 21.12.2004
PCT publication
WO2005/063819 14.07.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 21, 2024

    Maximum term reached

    Status of protective title
    Active → Cancelled
    Cancellation date
    21.12.2024
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 21.12.2024

  2. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  3. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  4. Jan 14, 2012

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 14.01.2012

  5. Dec 7, 2011

    Granted

    Published in Swissreg on 07.12.2011

Parties

Inventor

THROSBY, Mark

NL-3581 RB Utrecht, NL

VAN MEIJER, Marja

NL-1066 WS Amsterdam, NL

GERMERAAD, Wilfred Thomas Vincent

NL-6247 JA Gronsveld, NL

ARCECI, Robert John

Baltimore, MD 21212, US

KRUISBEEK, Ada Maria

NL-1066 EH Amsterdam, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.